[1] Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet, 2005; 365, 1415-28. doi:  10.1016/S0140-6736(05)66378-7
[2] M Trevisan, J Liu, FB Bahsas, et al. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol, 1998; 148, 958-66. doi:  10.1093/oxfordjournals.aje.a009572
[3] Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome-a new worldwide definition. Lancet, 2005; 366, 1059-62. doi:  10.1016/S0140-6736(05)67402-8
[4] Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am CollCardiol, 2010; 56, 1113-32. doi:  10.1016/j.jacc.2010.05.034
[5] Saito I. Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovasculardisease in Japan. Circ J, 2012; 76, 1066-73. doi:  10.1253/circj.CJ-11-1519
[6] Lu J, Wang L, Li M, et al. Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance. J Clin Endocrinol Metab, 2017; 102, 507-15. https://academic.oup.com/jcem/article/102/2/507/2972061
[7] Gobato AO, Vasques AC, Zambon MP, et al. Metabolic syndrome and insulin resistance in obese adolescents. Rev Paul Pediatr, 2014; 32, 55-62. doi:  10.1590/S0103-05822014000100010
[8] Zhong L, Li Q, Jiang Y, et al. The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population. Inflammation, 2010; 33, 353-8. doi:  10.1007/s10753-010-9193-4
[9] Voils SA, Cooper-DeHoff RM. Association between high sensitivity C-reactive protein and metabolic syndrome in subjects completing the National Health and Nutrition Examination Survey (NHANES) 2009-10. Diabetes Metab Syndr, 2014; 8, 88-90. doi:  10.1016/j.dsx.2014.04.021
[10] Galletti F, Barbato A, VersieroM, et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens, 2007; 25, 1671-7. doi:  10.1097/HJH.0b013e3281afa09e
[11] Kim DJ, Noh JH, Lee BW, et al. The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population. J Korean Med Sci, 2008; 23, 193-8. doi:  10.3346/jkms.2008.23.2.193
[12] Hiremath R, Ibrahim J, Prasanthi K, et al. Comparative Study of Ultrasonographic and Anthropometric Measurements of Regional Adiposity in Metabolic Syndrome. J Clin Diagn Res, 2017; 11, TC01-05. https://www.researchgate.net/publication/319245241_Comparative_Study_of_Ultrasonographic_and_Anthropometric_Measurements_of_Regional_Adiposity_in_Metabolic_Syndrome
[13] Wicklow BA, Becker A, Chateau D, et al. Comparison of anthropometric measurements in children to predict metabolic syndrome in adolescence: analysis of prospective cohort data. Int J Obes (Lond), 2015; 39, 1070-8. doi:  10.1038/ijo.2015.55
[14] Ramírez-Vélez R, Correa-Bautista JE, Sanders-Tordecilla A, et al. Percentage of Body Fat and Fat Mass Index as a Screening Tool for Metabolic Syndrome Prediction in Colombian University Students. Nutrients, 2017; 9. http://www.mdpi.com/2072-6643/9/9/1009/pdf
[15] Cornier MA, Després JP, Davis N, et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation, 2011; 124, 1996-2019. doi:  10.1161/CIR.0b013e318233bc6a
[16] Janssen I, Heymsfield SB, Wang ZM, et al. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol, (1985) 2000; 89, 81-8. https://www.researchgate.net/profile/Ian_Janssen/publication/306150258_Skeletal_muscle_mass_and_distribution_in_468_men_and_women_aged_18-88_yr/links/57ea97fe08aed3a3e08aae16.pdf?origin=publication_detail
[17] Friedrichsen M, Mortensen B, Pehmoller C, et al. Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity. Mol Cell Endocrinol, 2013; 366, 204-14. doi:  10.1016/j.mce.2012.06.013
[18] Febbraio MA, Pedersen BK. Contraction-induced myokine production and release:is skeletal muscle an endocrine organ? Exerc Sport Sci Rev, 2005; 33, 114-9. doi:  10.1097/00003677-200507000-00003
[19] Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab, 2011; 96, 2898-903. doi:  10.1210/jc.2011-0435
[20] Kim Y, Han BD, Han K, et al. Optimal cutoffs for low skeletal muscle mass related to cardiovascular risk in adults: The Korea National Health and Nutrition Examination Survey 2009-2010. Endocrine, 2015; 50, 424-33. doi:  10.1007/s12020-015-0577-y
[21] Kim TN, Choi KM. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. J Cell Biochem, 2015; 116, 1171-8. doi:  10.1002/jcb.v116.7
[22] Lu CW, Yang KC, Chang HH, et al. Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract, 2013; 7, e301-7. doi:  10.1016/j.orcp.2012.02.003
[23] Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care, 2010; 33, 1652-4. doi:  10.2337/dc10-0107
[24] Kurinami N, Sugiyama S, Yoshida A, et al. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naïve type 2 diabetes mellitus. Diabetes Res Clin Pract, 2016; 120, 65-72. doi:  10.1016/j.diabres.2016.07.018
[25] Thomson R, Brinkworth GD, Buckley JD, et al. Good agreement between bioelectrical impedance and dual-energy X-ray absorptiometry for estimating changes in body composition during weight loss in overweight young women. Clin Nutr, 2007; 26, 771-7. doi:  10.1016/j.clnu.2007.08.003
[26] Jaffrin MY, Kieffer R, Moreno MV. Evaluation of a foot-to-foot impedance meter measuring extracellular fluid volume in addition to fat-free mass and fat tissue mass. Nutrition, 2005; 21, 815-24. doi:  10.1016/j.nut.2004.11.016
[27] World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO consultation on obesity. World Health Organ Tech Rep Ser, 2000; 894: i-xii, 1-253. https://www.ncbi.nlm.nih.gov/pubmed/11234459
[28] Zimmet P, M M Alberti KG, Serrano Ríos M. A new international dia-betes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol, 2005; 58, 1371-6. doi:  10.1016/S0300-8932(05)74065-3
[29] National Bureau of Statistics of China (NBS). Tabulation on the 2010 Population Census of People's Republic of China; China Statistics Press: Beijing, China, 2012.
[30] Song QB, Zhao Y, Liu YQ, et al. Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: The CHPSNE study. Diab Vasc Dis Res, 2015; 12, 189-98. doi:  10.1177/1479164114562410
[31] Zhang YH, Dai HQ, Wu JJ, et al. Investigation on prevalence of themajor chronic diseases and its related risk factors among adult residents inDaxing district of Beijing city. Chin J Prey Contr Chron Dis, 2014; 4, 423-8. http://en.cnki.com.cn/Article_en/CJFDTotal-ZMXB201404014.htm
[32] Li JB, Wang X, Zhang JX, et al. Metabolicsyndrome: prevalence and risk factors in southern China. J Int Med Res, 2010; 38, 1142-8. doi:  10.1177/147323001003800343
[33] Tao R, Wu M, Qin Y, et al. Epidemiological characteristics of metabolic syndrome and comparison between its different diagnostic criteria in adults of Jiangsu Province. J Jilin Univ, 2015; 41, 181-9. doi:  10.1186/s12889-016-2870-y
[34] Xi B, He D, Hu Y, et al. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Prev Med, 2013; 57, 867-71. doi:  10.1016/j.ypmed.2013.09.023
[35] Li R, Li W, Lun Z, et al. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health, 2016; 16, 296. doi:  10.1186/s12889-016-2870-y
[36] Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey Ⅲ. PLoS One, 2010; 5, e10805. doi:  10.1371/journal.pone.0010805
[37] Guillet C, Boirie Y. Insulin resistance: a contributing factor to age-related muscle mass loss? Diabetes Metab, 2005; 31, 5S20-6. http://www.diabet-metabolism.com/article/S1262-3636 (05)73648-X/pdf
[38] Zamboni M, Mazzali G, Fantin F, et al. Sarcopenicobesity: A new category of obesity in the elderly. Nutr Metab Cardiovasc Dis, 2008; 18, 388-95. doi:  10.1016/j.numecd.2007.10.002
[39] Ferrara LA, Capaldo B, MancusiC, et al. Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the Strong Heart Study. Nutr Metab Cardiovasc Dis, 2014; 24, 271-6. doi:  10.1016/j.numecd.2013.08.009
[40] Chung JY, Kang HT, Lee DC, et al. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch GerontolGeriatr, 2013; 56, 270-8. http://europepmc.org/abstract/med/23079031